Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02631044
Recruitment Status : Recruiting
First Posted : December 15, 2015
Last Update Posted : October 12, 2018
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Juno Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : December 2020